Invention Grant
- Patent Title: Pyrrolobenzodiazepine-antibody conjugates
-
Application No.: US17380859Application Date: 2021-07-20
-
Publication No.: US11484606B2Publication Date: 2022-11-01
- Inventor: Patricius Hendrikus Cornelis Van Berkel
- Applicant: ADC THERAPEUTICS SA , MEDIMMUNE LIMITED
- Applicant Address: CH Epalinges; GB Cambridge
- Assignee: ADC THERAPEUTICS SA,MEDIMMUNE LIMITED
- Current Assignee: ADC THERAPEUTICS SA,MEDIMMUNE LIMITED
- Current Assignee Address: CH Epalinges; GB Cambridge
- Agency: Medler, Ferro, Woodhouse & Mills PLLC
- Priority: GB1908128 20190607
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61P35/00 ; C07K16/24
Abstract:
The present disclosure relates to pyrrolobenzodiazepines (PBDs) having a labile C2 or N10 protecting group in the form of a linker to an antibody.
Public/Granted literature
- US20220016261A1 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Public/Granted day:2022-01-20
Information query
IPC分类:
